IRVINE, Calif., April 20, 2011 /PRNewswire/ — Cardiogenesis
Corporation (OTCQB: CGCP) announced that the company will release
results for its first quarter ended March 31, 2011 on Wednesday,
May 4, 2011. The company added that Paul J. McCormick, its
Executive Chairman, and William R. Abbott, its Senior Vice
President and Chief Financial Officer, will host an investor
conference call that day at 5:00 p.m. Eastern time (2:00 p.m.
Pacific time) to review the company’s financial results and
business outlook.
The call is open to all interested investors through a live
audio broadcast via the Internet at www.cardiogenesis.com.
The call also will be available to investors and analysts by
dialing (800) 320-2978 within the U.S. and Canada and (617)
614-4923 from abroad. The passcode is 25661562.
The webcast will be archived on the company’s web site and will
be available for playback for seven days beginning shortly after
the live webcast. A telephonic playback of the conference
call will be available beginning at 8:00 p.m. Eastern time on
Wednesday, May 4, 2011 and continue through 8:00 p.m. Eastern time
on Wednesday, May 11, 2011. The replay can be accessed by
calling (888) 286-8010 within the U.S. and Canada and (617)
801-6888 from abroad. The replay passcode is 18993459.
About Cardiogenesis Corporation
Cardiogenesis is a medical device company specializing in the
treatment of cardiovascular disease and is a leader in devices that
stimulate cardiac angiogenesis. The company’s market leading
Holmium:YAG laser system and disposable fiber-optic accessories are
used to perform an FDA-cleared surgical procedure known as
Transmyocardial Revascularization (TMR) to treat patients suffering
from angina. Surgical products and accessories for the
Cardiogenesis TMR procedure, which are marketed in the U.S. and
around the world, have been shown to reduce angina a
‘/>”/>
SOURCE
